LFST - NASDAQ
LifeStance Health Group, Inc.
$7.50
-5.5%LifeStance Health Group, Inc., through its subsidiaries, provides outpatient mental health services. The company offers patients a suite of mental health services, including psychiatric evaluations and treatment, psychological, and neuropsychological testing, as well as individual, family, and group therapy. It treats a range of mental health conditions, including anxiety, depression, bipolar disorder, eating disorders, psychotic disorders, and post-traumatic stress disorder. In addition, the company operates outpatient mental health platform as well as offers patients care virtually through its online delivery platform or in-person at its centers in 32 states. It serves children, adolescents, adults, and geriatrics. LifeStance Health Group, Inc. was founded in 2017 and is based in Scottsdale, Arizona.
At a Glance
Live SnapshotLifeStance Health Group, Inc. Profit Bridge
Profitability Analysis
Gross Margin
Moderate margins typical of competitive industries. Monitor for pricing pressure or rising costs.
Operating Margin
Minimal operating profit suggests high operating costs or pricing challenges. Scalability is concerning.
Net Profit Margin
Minimal profitability after all expenses. Limited financial flexibility for reinvestment or shareholder returns.
Effective Tax Rate
Moderate tax rate typical for most corporations. Represents standard tax burden on profits.
Profitability Insight
Room for improvement: Moderate profitability with opportunities to enhance margins through better cost management or pricing strategy.
LifeStance Health Group, Inc. Income Statement
LFST • NASDAQ
| LifeStance Health Group, Inc. Income Statement | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 |
|---|---|---|---|---|---|---|---|
REVENUE | |||||||
1.4B | 1.3B | 1.1B | 859.5M | 667.5M | 377.2M | 212.5M | |
GROSS PROFIT | |||||||
(1B) | (848.6M) | (753.6M) | (622.5M) | (466M) | (242.9M) | (150.1M) | |
406.3M | 402.4M | 302.1M | 237M | 201.5M | 134.3M | 62.4M | |
OPERATING INCOME | |||||||
(380.6M) | (434M) | (491.2M) | (447.2M) | (487.9M) | (118.9M) | (47.2M) | |
(382.2M) | (363.1M) | (410.8M) | (378M) | (433.7M) | (87.8M) | (41.1M) | |
25.7M | -31.6M | -189.1M | -210.2M | -286.4M | 15.4M | 15.2M | |
PRE-TAX INCOME | |||||||
(11.7M) | (26.5M) | (21.2M) | (19.9M) | (38.9M) | (22.1M) | (5.4M) | |
-11.7M | -26.5M | -21.2M | -19.9M | -38.9M | 0.0 | -5.4M | |
(0.0) | (71M) | (80.4M) | (69.2M) | (54.1M) | (31M) | (6.1M) | |
-13.3M | -26M | -17.4M | -22.6M | -46.8M | -59.8M | -7.4M | |
12.4M | -57.6M | -206.6M | -232.7M | -333.1M | -44.4M | 7.9M | |
NET INCOME | |||||||
(2.7M) | -170K | -20.3M | -17.2M | -25.9M | -6.3M | (2.2M) | |
9.7M | -57.4M | -186.3M | -215.6M | -307.2M | -38.1M | 5.7M |
SEC Filings
LFST - Filing history and reports
| Filing Type | Filing Date | Period Ending | Fiscal Year | Actions |
|---|---|---|---|---|
8-K 8-K 2026 N/A | May 12, 2026 | May 07, 2026 | 2026 | |
10-Q 10-Q 2026 Q1 Q1 | May 07, 2026 | March 31, 2026 | 2026 | |
8-K 8-K 2026 N/A | May 07, 2026 | May 07, 2026 | 2026 | |
DEF 14A DEF 14A 2026 N/A | April 22, 2026 | June 02, 2026 | 2026 | |
8-K 8-K 2026 N/A | March 11, 2026 | March 10, 2026 | 2026 | |
8-K 8-K 2026 N/A | March 02, 2026 | February 25, 2026 | 2026 | |
10-K 10-K 2025 FY FY | February 25, 2026 | December 31, 2025 | 2025 | |
8-K 8-K 2026 N/A | February 25, 2026 | February 25, 2026 | 2026 | |
10-Q 10-Q 2025 Q3 Q3 | November 06, 2025 | September 30, 2025 | 2025 | |
8-K 8-K 2025 N/A | November 06, 2025 | November 06, 2025 | 2025 |
Related Guides
Continue your LFST research with focused valuation guides.
Research Paths
Snapshot
Start with context, operating signals, and key market metrics.
Value Model
Stress test fair value across bear, base, and bull assumptions.
Statements
Validate revenue quality, margins, and balance sheet durability.
Earnings Call
Read management commentary and compare it with reported outcomes.
Dividends
Check payout sustainability and long-term distribution behavior.
Analyst Expectations
Review consensus spread and where estimate risk is concentrated.